Cargando…

Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record

BACKGROUND: Adverse drug events (ADEs), harmful unintended consequences of medication use, are a leading cause of hospital admissions, yet are rarely documented in a structured format between care providers. We describe pilot-testing structured ADE documentation fields prior to integration into an e...

Descripción completa

Detalles Bibliográficos
Autores principales: Chruscicki, Adam, Badke, Katherin, Peddie, David, Small, Serena, Balka, Ellen, Hohl, Corinne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056922/
https://www.ncbi.nlm.nih.gov/pubmed/27795906
http://dx.doi.org/10.1186/s40064-016-3382-z
_version_ 1782458966075244544
author Chruscicki, Adam
Badke, Katherin
Peddie, David
Small, Serena
Balka, Ellen
Hohl, Corinne M.
author_facet Chruscicki, Adam
Badke, Katherin
Peddie, David
Small, Serena
Balka, Ellen
Hohl, Corinne M.
author_sort Chruscicki, Adam
collection PubMed
description BACKGROUND: Adverse drug events (ADEs), harmful unintended consequences of medication use, are a leading cause of hospital admissions, yet are rarely documented in a structured format between care providers. We describe pilot-testing structured ADE documentation fields prior to integration into an electronic medical record (EMR). METHODS: We completed a qualitative study at two Canadian hospitals. Using data derived from a systematic review of the literature, we developed screen mock-ups for an ADE reporting platform, iteratively revised in participatory workshops with diverse end-user groups. We designed a paper-based form reflecting the data elements contained in the mock-ups. We distributed them to a convenience sample of clinical pharmacists, and completed ethnographic workplace observations while the forms were used. We reviewed completed forms, collected feedback from pharmacists using semi-structured interviews, and coded the data in NVivo for themes related to the ADE form. RESULTS: We completed 25 h of clinical observations, and 24 ADEs were documented. Pharmacists perceived the form as simple and clear, with sufficient detail to capture ADEs. They identified fields for omission, and others requiring more detail. Pharmacists encountered barriers to documenting ADEs including uncertainty about what constituted a reportable ADE, inability to complete patient follow-up, the need for inter-professional communication to rule out alternative diagnoses, and concern about creating a permanent record. CONCLUSION: Paper-based pilot-testing allowed planning for important modifications in an ADE documentation form prior to implementation in an EMR. While paper-based piloting is rarely reported prior to EMR implementations, it can inform design and enhance functionality. Piloting with other groups of care providers and in different healthcare settings will likely lead to further revisions prior to broader implementations.
format Online
Article
Text
id pubmed-5056922
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-50569222016-10-28 Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record Chruscicki, Adam Badke, Katherin Peddie, David Small, Serena Balka, Ellen Hohl, Corinne M. Springerplus Research BACKGROUND: Adverse drug events (ADEs), harmful unintended consequences of medication use, are a leading cause of hospital admissions, yet are rarely documented in a structured format between care providers. We describe pilot-testing structured ADE documentation fields prior to integration into an electronic medical record (EMR). METHODS: We completed a qualitative study at two Canadian hospitals. Using data derived from a systematic review of the literature, we developed screen mock-ups for an ADE reporting platform, iteratively revised in participatory workshops with diverse end-user groups. We designed a paper-based form reflecting the data elements contained in the mock-ups. We distributed them to a convenience sample of clinical pharmacists, and completed ethnographic workplace observations while the forms were used. We reviewed completed forms, collected feedback from pharmacists using semi-structured interviews, and coded the data in NVivo for themes related to the ADE form. RESULTS: We completed 25 h of clinical observations, and 24 ADEs were documented. Pharmacists perceived the form as simple and clear, with sufficient detail to capture ADEs. They identified fields for omission, and others requiring more detail. Pharmacists encountered barriers to documenting ADEs including uncertainty about what constituted a reportable ADE, inability to complete patient follow-up, the need for inter-professional communication to rule out alternative diagnoses, and concern about creating a permanent record. CONCLUSION: Paper-based pilot-testing allowed planning for important modifications in an ADE documentation form prior to implementation in an EMR. While paper-based piloting is rarely reported prior to EMR implementations, it can inform design and enhance functionality. Piloting with other groups of care providers and in different healthcare settings will likely lead to further revisions prior to broader implementations. Springer International Publishing 2016-10-11 /pmc/articles/PMC5056922/ /pubmed/27795906 http://dx.doi.org/10.1186/s40064-016-3382-z Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Chruscicki, Adam
Badke, Katherin
Peddie, David
Small, Serena
Balka, Ellen
Hohl, Corinne M.
Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record
title Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record
title_full Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record
title_fullStr Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record
title_full_unstemmed Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record
title_short Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record
title_sort pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056922/
https://www.ncbi.nlm.nih.gov/pubmed/27795906
http://dx.doi.org/10.1186/s40064-016-3382-z
work_keys_str_mv AT chruscickiadam pilottestinganadversedrugeventreportingformpriortoitsimplementationinanelectronichealthrecord
AT badkekatherin pilottestinganadversedrugeventreportingformpriortoitsimplementationinanelectronichealthrecord
AT peddiedavid pilottestinganadversedrugeventreportingformpriortoitsimplementationinanelectronichealthrecord
AT smallserena pilottestinganadversedrugeventreportingformpriortoitsimplementationinanelectronichealthrecord
AT balkaellen pilottestinganadversedrugeventreportingformpriortoitsimplementationinanelectronichealthrecord
AT hohlcorinnem pilottestinganadversedrugeventreportingformpriortoitsimplementationinanelectronichealthrecord